Related Experiment Video
Updated: Oct 24, 2025
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Update on Molecular Imaging and Precision Medicine in Lung Cancer
Katherine A Zukotynski1, Olfat Kamel Hasan1, Matthew Lubanovic2
1Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, Ontario L9G 4X5, Canada; Department of Radiology, McMaster University, 1200 Main Street West, Hamilton, Ontario L9G 4X5, Canada.
Precision medicine tailors lung cancer treatment by integrating patient data for better outcomes. Positron Emission Tomography (PET) imaging aids in personalizing therapy and predicting treatment response.
Area of Science:
- Oncology
- Medical Imaging
- Genomics
Background:
- Precision medicine revolutionizes healthcare by tailoring treatments to individual patients.
- Lung cancer is a complex and heterogeneous disease requiring personalized therapeutic strategies.
- Tumor evolution can lead to treatment resistance, necessitating dynamic monitoring.
Purpose of the Study:
- To highlight the role of Positron Emission Tomography (PET) in precision medicine for lung cancer.
- To demonstrate how PET imaging can guide treatment selection and predict patient outcomes.
- To underscore the importance of integrating molecular and imaging data for personalized lung cancer care.
Main Methods:
- Review of current literature on precision medicine in lung cancer.
- Analysis of PET imaging's utility in diagnosis, staging, and restaging.
- Evaluation of PET as a prognostic biomarker for treatment response.
Main Results:
- PET provides crucial anatomo-functional insights for lung cancer management.
- PET imaging characterizes tumoral heterogeneity and predicts early treatment response.
- PET serves as a prognostic biomarker, aiding in treatment selection and outcome prediction.
Conclusions:
- PET imaging is integral to the precision medicine approach for lung cancer.
- Integrating PET with molecular data enhances personalized treatment strategies.
- PET imaging facilitates optimal treatment decisions, improving patient outcomes in lung cancer.
More Related Videos
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013